20 August 2015 - Thousands of cancer patients are missing out on personalised treatments each year in England because they are not being given a test to see if they might benefit from them, according to a new report from Cancer Research UK.

The report looked at the NHS’s molecular diagnostic testing service for cancer patients in England. These are tests that can identify the genetic faults underpinning a patient’s cancer, some of which can be hit with targeted therapies. The report focused on patients with skin, lung and bowel cancer, where targeted drugs are already available on the NHS.

For more details, go to: http://www.cancerresearchuk.org/about-us/cancer-news/press-release/2015-08-20-thousands-of-patients-missing-out-on-targeted-cancer-drugs